OTC Watch

All stocks / VCNX

VACCINEX, INC. VCNX

Vaccinex (VCNX): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Limited disclosure Pink LimitedNew York, USA
Live quote on OTC Markets

Market listing

Full name
VACCINEX INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 16
Website
ir.vaccinex.com/
Source: Stockwatch, 2026-11-17

News headlines

Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer's Association International Conference in London on July 13, 2026
2026-07-08 08:30 · News Release
Vaccinex Reports 2025 Annual Financial Results
2026-04-29 20:05 · News Release
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer's Disease
2025-12-23 08:01 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2024-12-31
The report says
Revenue
$601,000
Net loss
($18,634,000)
What it means

It spends more than it earns

Under strain

Customers paid it $601,000 in the year. It lost $18.6 million. For every $1 that came in, about $32.00 went out.

The report says
Cash and cash equivalents
$1,107,000
Net cash used in operating activities
($16,186,000)
What it means

The cash could run out soon

Under strain

It had $1.1 million in the bank and used about $1.3 million a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$2,596,000
Total liabilities
$5,084,000
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $2.6 million. Its debts and unpaid bills add up to $5.1 million. That is about $1.96 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Limited disclosure2026-11-17

No filings on SEC EDGAR in the last 12 months.

Rule: No SEC filings in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2024-03-22
1.2M
2024-03-31
1.6M
2024-05-10
1.6M
2024-08-09
1.7M
2024-09-30
2.6M
2024-11-12
2.6M
2024-12-31
2.7M
2025-04-11
2.7M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Common questions about VCNX

Does VCNX file reports with the SEC?

Yes. Vaccinex files with the SEC under company number 0001205922. We found no filings from it in the last 12 months.

Source record

How many VCNX shares are outstanding?

2,676,637 shares as of 2025-04-11, as reported to the SEC.

Source record

Has VCNX filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Vaccinex making money?

Customers paid it $601,000 in the year. It lost $18.6 million. For every $1 that came in, about $32.00 went out. (Annual figures to 2024-12-31. Facts from the company's own report, not a recommendation.)

Source record